188 related articles for article (PubMed ID: 34655595)
21. Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.
Fan NJ; Tang JJ; Li H; Li XJ; Luo B; Gao JM
Eur J Med Chem; 2013 Nov; 69():182-90. PubMed ID: 24021891
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity.
Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM
Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.
Lusardi M; Signorello MG; Russo E; Caviglia D; Ponassi M; Iervasi E; Rosano C; Brullo C; Spallarossa A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731825
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antiproliferative activity of D-ring substituted steroidal benzamidothiazoles.
Fan NJ; He QR; Duan M; Bai YB; Tang JJ
Steroids; 2016 Aug; 112():103-8. PubMed ID: 27137356
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.
Lu Y; Wang Z; Li CM; Chen J; Dalton JT; Li W; Miller DD
Bioorg Med Chem; 2010 Jan; 18(2):477-95. PubMed ID: 20056548
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
[TBL] [Abstract][Full Text] [Related]
29. Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
Abdel-Maksoud MS; Mohamed Hassan R; Abdel-Sattar El-Azzouny A; Nabil Aboul-Enein M; Oh CH
Bioorg Chem; 2021 Dec; 117():105424. PubMed ID: 34678604
[TBL] [Abstract][Full Text] [Related]
30. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, in vitro anticancer activity and in silico studies of certain pyrazole-based derivatives as potential inhibitors of cyclin dependent kinases (CDKs).
Mohammed EZ; Mahmoud WR; George RF; Hassan GS; Omar FA; Georgey HH
Bioorg Chem; 2021 Nov; 116():105347. PubMed ID: 34555628
[TBL] [Abstract][Full Text] [Related]
33. Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents.
Samanta S; Ghosh AK; Ghosh S; Ilina AA; Volkova YA; Zavarzin IV; Scherbakov AM; Salnikova DI; Dzichenka YU; Sachenko AB; Shirinian VZ; Hajra A
Org Biomol Chem; 2020 Aug; 18(29):5571-5576. PubMed ID: 32662797
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents.
Wang C; Yang S; Du J; Ni J; Wu Y; Wang J; Guan Q; Zuo D; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2019 Jun; 171():1-10. PubMed ID: 30901597
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors.
Ravula P; Vamaraju HB; Paturi M; Sharath Chandra JNGN
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29205467
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarylpyrazole derivatives possessing arylamides or arylureas moieties.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2016 Aug; 119():122-31. PubMed ID: 27155467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
